PRIMACOR is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. Patients receiving PRIMACOR should be observed closely with appropriate electrocardiographic equipment. The facility for immediate treatment of potential cardiac events, which may include life threatening ventricular arrhythmias, must be available. The majority of experience with intravenous PRIMACOR has been in patients receiving digoxin and diuretics. There is no experience in controlled trials with infusions of PRIMACOR for periods exceeding 48 hours.
Manufacturers URL : www.bbraun.com
To be the first to submit a review
for this item, use the link displayed above.
Subscribe to review alerts?
Would you like to be notified about each new review that comes in for this item?
Enter your email address below and subscribe. Your e-mail address will
not be used for anything other than sending these alerts.